Skip to main content
. 2022 Jun 25;87:e281–e285. doi: 10.5114/pjr.2022.116913

Table 4.

Leiomyoma presence in patients from the adenomyosis group and the control group

Variables Group A Control group p-value
Leiomyoma, n(%) 62 (24.6) 33 (16.3) 0.024
C/S history, n(%) 67 (26.5) 42(20.7) 0.015